Fred Reno

During his over 40 years career in the pharmaceutical and biotechnology sectors, Fred has provided scientific expertise in the areas of toxicology, preclinical aspects of drug and device development, strategies for product safety evaluation, and liaison with appropriate regulatory agencies.

His experience includes; organizing and directing safety evaluation programs and interfacing with contract laboratories; providing scientific opinions on toxicology aspects of potential candidate compounds for licensing; and preparation of preclinical summariesfor U.S. (IND, NDA, IDE, PMA) and foreign pharmaceutical submissions. Working together with Colleen Johnson, Fred has led the IND enabling and subsequent toxicology program for EMA401.

Fred has Ph.D., Toxicology from Utah State University, M.S., Zoology from University of Nevada and B.S., Biology from University of San Francisco.

Fred Reno is the VP of Toxicology & Consultant at Spinifex Pharmaceuticals, based in Europe. With a background in Biotechnology, Fred Reno has a rich history of leadership and innovation.Fred Reno studied Ph.D. Toxicology at Utah State University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.